Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$7.06 - $23.63 $4,024 - $13,469
570 Added 2.03%
28,708 $240,000
Q1 2022

May 11, 2022

BUY
$21.6 - $27.79 $3,888 - $5,002
180 Added 0.64%
28,138 $643,000
Q4 2021

Jan 10, 2022

BUY
$23.0 - $29.01 $88,090 - $111,108
3,830 Added 15.87%
27,958 $772,000
Q3 2021

Oct 21, 2021

BUY
$25.04 - $30.06 $604,165 - $725,287
24,128 New
24,128 $672,000
Q3 2021

Oct 13, 2021

SELL
$25.04 - $30.06 $580,877 - $697,331
-23,198 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$27.43 - $32.7 $23,864 - $28,449
-870 Reduced 3.61%
23,198 $680,000
Q1 2021

Apr 15, 2021

SELL
$21.37 - $34.38 $55,049 - $88,562
-2,576 Reduced 9.67%
24,068 $764,000
Q4 2020

Jan 14, 2021

BUY
$15.31 - $21.12 $27,864 - $38,438
1,820 Added 7.33%
26,644 $554,000
Q3 2020

Oct 08, 2020

BUY
$14.88 - $20.13 $5,356 - $7,246
360 Added 1.47%
24,824 $386,000
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $7,187 - $11,075
540 Added 2.26%
24,464 $447,000
Q1 2020

Apr 28, 2020

BUY
$12.98 - $30.25 $40,757 - $94,985
3,140 Added 15.11%
23,924 $370,000
Q4 2019

Feb 06, 2020

BUY
$18.89 - $31.89 $11,711 - $19,771
620 Added 3.07%
20,784 $622,000
Q3 2019

Oct 09, 2019

SELL
$20.88 - $25.66 $43,910 - $53,962
-2,103 Reduced 9.44%
20,164 $441,000
Q2 2019

Jul 09, 2019

BUY
$20.52 - $26.45 $615 - $793
30 Added 0.13%
22,267 $562,000
Q1 2019

May 02, 2019

BUY
$20.23 - $26.29 $27,512 - $35,754
1,360 Added 6.51%
22,237 $549,000
Q4 2018

Jan 31, 2019

SELL
$17.64 - $28.32 $42,900 - $68,874
-2,432 Reduced 10.43%
20,877 $386,000
Q3 2018

Nov 08, 2018

BUY
$20.64 - $25.67 $481,097 - $598,342
23,309 New
23,309 $598,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.